Search

Your search keyword '"Levin, Edward D."' showing total 196 results

Search Constraints

Start Over You searched for: Author "Levin, Edward D." Remove constraint Author: "Levin, Edward D." Topic nicotine Remove constraint Topic: nicotine
196 results on '"Levin, Edward D."'

Search Results

1. Acute and chronic glutamate NMDA antagonist treatment attenuates dopamine D 1 antagonist-induced reduction of nicotine self-administration in female rats.

2. Impact of acute nicotine exposure on monoaminergic systems in adolescent and adult male and female rats.

3. Time-dependent effects of nicotine on reversal of dizocilpine-induced attentional impairment in female rats.

4. Chronic infusions of mecamylamine into the medial habenula: Effects on nicotine self-administration in rats.

5. Self-administration by female rats of low doses of nicotine alone vs. nicotine in tobacco smoke extract.

6. Sperm DNA methylation altered by THC and nicotine: Vulnerability of neurodevelopmental genes with bivalent chromatin.

7. This is your teen brain on drugs: In search of biological factors unique to dependence toxicity in adolescence.

8. Prolonging the Reduction of Nicotine Self-Administration in Rats by Coadministering Chronic Nicotine With Amitifadine, a Triple Monoamine Reuptake Inhibitor With CYP2B6 Inhibitory Actions.

9. Acute and chronic interactive treatments of serotonin 5HT 2C and dopamine D 1 receptor systems for decreasing nicotine self-administration in female rats.

10. Gestational exposure to nicotine and/or benzo[a]pyrene causes long-lasting neurobehavioral consequences.

11. Chronic memantine decreases nicotine self-administration in rats.

12. Paternal nicotine exposure in rats produces long-lasting neurobehavioral effects in the offspring.

13. Oral sazetidine-A, a selective α4β2* nicotinic receptor desensitizing agent, reduces nicotine self-administration in rats.

14. Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D 1 receptor antagonist SCH-23390 or the serotonin 5-HT 2C agonist lorcaserin.

15. The Developmental Neurotoxicity of Tobacco Smoke Can Be Mimicked by a Combination of Nicotine and Benzo[a]Pyrene: Effects on Cholinergic and Serotonergic Systems.

16. Sub-anesthetic doses of ketamine attenuate nicotine self-administration in rats.

17. Mutually augmenting interactions of dextromethorphan and sazetidine-A for reducing nicotine self-administration in rats.

18. Differential efficacies of the nicotinic α4β2 desensitizing agents in reducing nicotine self-administration in female rats.

19. Acute oral 18-methoxycoronaridine (18-MC) decreases both alcohol intake and IV nicotine self-administration in rats.

20. Reduction of nicotine self-administration by chronic nicotine infusion with H1 histamine blockade in female rats.

21. Cognitive and Behavioral Impairments Evoked by Low-Level Exposure to Tobacco Smoke Components: Comparison with Nicotine Alone.

22. Dextromethorphan interactions with histaminergic and serotonergic treatments to reduce nicotine self-administration in rats.

23. Amitifadine, a triple monoamine re-uptake inhibitor, reduces nicotine self-administration in female rats.

24. Teratogenic, bioenergetic, and behavioral effects of exposure to total particulate matter on early development of zebrafish (Danio rerio) are not mimicked by nicotine.

25. Developmental Neurotoxicity of Tobacco Smoke Directed Toward Cholinergic and Serotonergic Systems: More Than Just Nicotine.

26. Bupropion-varenicline interactions and nicotine self-administration behavior in rats.

27. Prenatal nicotine changes the response to postnatal chlorpyrifos: Interactions targeting serotonergic synaptic function and cognition.

28. Heterogeneity across brain regions and neurotransmitter interactions with nicotinic effects on memory function.

29. IV nicotine self-administration in rats using a consummatory operant licking response: sensitivity to serotonergic, glutaminergic and histaminergic drugs.

30. Differential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in rats.

31. Effects of tobacco smoke on PC12 cell neurodifferentiation are distinct from those of nicotine or benzo[a]pyrene.

32. Role of insular cortex D₁ and D₂ dopamine receptors in nicotine self-administration in rats.

33. Effects of caffeine on alcohol consumption and nicotine self-administration in rats.

34. Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats.

35. Threshold of adulthood for the onset of nicotine self-administration in male and female rats.

36. Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats.

37. D-cycloserine selectively decreases nicotine self-administration in rats with low baseline levels of response.

38. Histamine H(1) antagonist treatment with pyrilamine reduces nicotine self-administration in rats.

39. Zebrafish assessment of cognitive improvement and anxiolysis: filling the gap between in vitro and rodent models for drug development.

40. IV nicotine self-administration in rats using the consummatory operant licking response.

41. Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.

42. Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats.

43. Zebrafish provide a sensitive model of persisting neurobehavioral effects of developmental chlorpyrifos exposure: comparison with nicotine and pilocarpine effects and relationship to dopamine deficits.

44. Nicotine effects on learning in zebrafish: the role of dopaminergic systems.

45. Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

46. The role of alpha7 and alpha4beta2 nicotinic receptors in the nicotine-induced anxiolytic effect in zebrafish.

47. Idazoxan blocks the nicotine-induced reversal of the memory impairment caused by the NMDA glutamate receptor antagonist dizocilpine.

48. Chronic nicotine and dizocilpine effects on nicotinic and NMDA glutamatergic receptor regulation: interactions with clozapine actions and attentional performance in rats.

49. Nicotine and clozapine effects on attentional performance impaired by the NMDA antagonist dizocilpine in female rats.

50. Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.

Catalog

Books, media, physical & digital resources